Lexicon Pharmaceuticals, Inc.(NASDAQ : LXRX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.29%||79.74||0.9%||$563.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.06%||126.75||2.0%||$276.96m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.50%||343.30||2.7%||$275.56m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.97%||175.66||1.9%||$265.02m|
|A||Agilent Technologies, Inc.||-0.43%||69.88||1.5%||$176.42m|
|EXAS||Exact Sciences Corporation||0.92%||52.57||25.7%||$143.36m|
|SRPT||Sarepta Therapeutics, Inc.||-0.37%||80.92||16.7%||$123.27m|
|BLUE||Bluebird Bio, Inc.||-6.92%||199.80||15.8%||$122.80m|
|BMRN||BioMarin Pharmaceutical Inc.||0.63%||84.10||4.4%||$104.37m|
Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.